The Psychopharmacology of Obsessive Compulsive Disorder: Implications for Treatment and Pathogenesis
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Recent advances in the pharmacotherapy of obsessive compulsive disorder (OCD) have led to a significant reduction in suffering and a return to productive living for many patients previously considered refractory to treatment. Potent inhibitors of 5-hydroxytryptamine (5-HT) re-uptake clearly have been established as the first-line pharmacotherapy for treatment of OCD. The addition of agents that enhance 5-HT neurotransmission to ongoing treatment in patients whose OCD is refractory to 5-HT re-uptake inhibitors has not yielded impressive results. The addition of dopamine (DA) antagonists to the regimens of treatment-resistant patients appears to be a potentially useful strategy for the specific subgroup of OCD patients with a comorbid chronic tic disorder such as Tourette's syndrome. Pharmacologic studies suggest that both the 5-HT and DA systems may be critical to the treatment and possibly the pathophysiology of OCD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Yale-Brown Obsessive Compulsive Scale: II. Validity
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110054008 · Cited by 2,799
Self-citationGawin, F. H., & Ellinwood, E. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181806 · Cited by 965
Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.12.1560 · Cited by 541
Clomipramine Treatment of Obsessive-Compulsive Disorder: I. A Controlled Clinical Trial
Thorén, P. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780240079009 · Cited by 497
Clomipramine Treatment of Childhood Obsessive-Compulsive Disorder: A Double-blind Controlled Study
Flament, M. F. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790330057007 · Cited by 466
High prevalence of obsessive–compulsive symptoms in patients with Sydenham's chorea
(1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.2.246 · Cited by 421
LAPLANE, D., LEVASSEUR, M., PILLON, B., DUBOIS, B., BAULAC, M., MAZOYER, B., DINH, S. T., SETTE, G., DANZE, F., & BARON, J. C. (1989) · Brain · doi:10.1093/brain/112.3.699 · Cited by 415
Obsessive-compulsive disorder and serotonin: Is there a connection?
Insel, T. R., Mueller, E. A., Alterman, I., Linnoila, M., & Murphy, D. L. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90176-3 · Cited by 343
Failure in treating obsessive–compulsives
Foa, E. B. (1979) · Behaviour Research and Therapy · doi:10.1016/0005-7967(79)90031-7 · Cited by 305
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.9.1089 · Cited by 284
Cited by
Treatment non-response in OCD: methodological issues and operational definitions
Pallanti, S., Hollander, E., Bienstock, C., Koran, L., Leckman, J., Marazziti, D., Pato, M., Stein, D., Zohar, J., & International Treatment Refractory OCD Consortium (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002900 · Cited by 416
Self-citationPallanti, S., & Quercioli, L. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.028 · Cited by 408
“…generally irrelevant to treatment response (Katz and DeVeaugh-Geiss, 1990; Mavissakalian et al., 1985), a lower response rate has been observed with comorbid chronic tic disorder (Goodman et al., 1992; McDougle et al., 1993a,b) and OCD patients with neurological soft signs (Hollander et al., 1990).”
BackgroundStein, D. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09620-4 · Cited by 352
Fluvoxamine Treatment and D2 Receptors: a Pet Study on OCD Drug-Naïve Patients
Moresco, R. M., Pietra, L., Henin, M., Panzacchi, A., Locatelli, M., Bonaldi, L., Carpinelli, A., Gobbo, C., Bellodi, L., Perani, D., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301199 · Cited by 70
Combining Pharmacotherapy with Cognitive‐Behavioral Interventions for Obsessive‐Compulsive Disorder
Cottraux, J., Bouvard, M. A., & Milliery, M. (2005) · Cognitive Behaviour Therapy · doi:10.1080/16506070510043750 · Cited by 60
“Despite these useful guidelines, as many as 40–60% of OCD patients remain clinically unchanged after an adequate trial of medication (McDougle et al., 1993).”
Background
Metadata
- Authors
- McDougle, C. J., Goodman, W. K., Leckman, J. F., & Price, L. H.
- Venue
- Psychiatric Clinics of North America
- Publisher
- Elsevier BV
- Published
- 1993-12
- Volume
- 16
- Issue
- 4
- Pages
- 749-766
- ISSN
- 0193-953X (ISSN-L)
- OpenAlex
- W1710919659
- Cited by
- 80
- References
- 12
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Psychopharmacology of Obsessive Compulsive Disorder: Implications for Treatment and Pathogenesis. https://app.cochat.ai/papers/10.1016/s0193-953x(18)30148-5
- The paper
- McDougle, C. J., Goodman, W. K., Leckman, J. F., & Price, L. H. (1993). The Psychopharmacology of Obsessive Compulsive Disorder: Implications for Treatment and Pathogenesis. Psychiatric Clinics of North America. https://doi.org/10.1016/s0193-953x(18)30148-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.